Saturday
SESSION 45: LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
SESSION 45 SCHEDULE
12:01 PM - 12:06 PM Off-The-Shelf Fenestrated VENTANA Device For Renal Revascularization With Juxta And Pararenal AAAs: Clinical Update And Will In Situ Fenestration Be Possible With Newer Multilayer Stretchable PTFE Endograft Coverings
  Presenter(s):Daniel G. Clair, MD  
12:07 PM - 12:12 PM Recent Improvements In The Cook Zenith AAA Endograft: How Do They Make A Difference
  Presenter(s):Tara M. Mastracci, MD  
12:13 PM - 12:18 PM Update On Advantages And Limitations Of The Lombard AORFIX Graft: When Will It Be Approved In The US
  Presenter(s):Brian R. Hopkinson, ChM, FRCS / Mark F. Fillinger, MD  
  View Abstract      
12:19 PM - 12:24 PM Worldwide Experience With The Aptus HELIFX Endostaples: Can They Fix Endoleaks And Prevent Aortic Neck Enlargement And Migration
  Presenter(s):David H. Deaton, MD  
12:25 PM - 12:30 PM Update On The NELLIX Device For EVAR: Advantages And Limitations
  Presenter(s):Jeffrey P. Carpenter, MD  
12:31 PM - 12:36 PM Advantages And Limitations Of The INCRAFT From Cordis: 1-Year Clinical Data From The INNOVATION Trial
  Presenter(s):Gioacchino Coppi, MD / Dierk Scheinert, MD  
12:37 PM - 12:42 PM Description And Clinical Experience With The Anaconda Fenestrated Endograft For Juxta And Pararenal AAAs
  Presenter(s):Clark J. Zeebregts, MD, PhD  
12:43 PM - 12:48 PM Worldwide Mid-Term Results (2-Year) Of The Endurant Endograft For AAAs: Does It Expand The Proportion Of Patients Who Can Undergo EVAR Safely And Effectively
  Presenter(s):Dittmar Boeckler, MD / Michel S. Makaroun, MD  
12:49 PM - 12:54 PM Current Status Of The Bolton TREOVANCE AAA Endograft: Advantages And Limitations
  Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD  
12:55 PM - 1:00 PM Panel Discussion
END OF SESSION 45
previous next